Hemiasterlin analogues incorporating an aromatic, and heterocyclic type C-terminus: design, synthesis and biological evaluation

No abstract is available for this paper.

• Publication year

  2014

• Venue

  Molecular diversity

• Publication date

  2014-02-06

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1007/s11030-014-9507-9PMID 24500310PMCID PMC4081462
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The Mitotic Spindle

  2016cited by this paper
• Corrigendum to “Absolute configurations of tubulin inhibitors taltobulin (HTI-286) and HTI-042 characterized by X-ray diffraction analysis and NMR studies” [Bioorg. Med. Chem. Lett. 20 (2010) 1535–1538]

  2012cited by this paper
• Development of hemiasterlin derivatives as potential anticancer agents that inhibit tubulin polymerization and synergize with a stilbene tubulin inhibitor

  2012cited by this paper
• New insights into mechanisms of resistance to microtubule inhibitors.

  2011cited by this paper
• Versatile synthesis of new cytotoxic agents structurally related to hemiasterlins.

  2010cited by this paper
• The Preparation of Optically Active α-Amino 4H-[1,2,4]Oxadiazol-5-ones from Optically Active α-Amino Acids.

  2010cited by this paper
• Absolute configurations of tubulin inhibitors taltobulin (HTI-286) and HTI-042 characterized by X-ray diffraction analysis and NMR studies.

  2010cited by this paper
• Microtubule-binding agents: a dynamic field of cancer therapeutics

  2010cited by this paper
• Annulated diketopiperazines from dipeptides or Schöllkopf reagents via tandem cyclization-intramolecular N-arylation.

  2010cited by this paper
• Hemiasterlin Analogues with Unnatural Amino Acids at the N-Terminal and Their Inhibitory Activity on Tumor Cells

  2009cited by this paper
• Tubulin-based antimitotic mechanism of E7974, a novel analogue of the marine sponge natural product hemiasterlin

  2009cited by this paper
• Drug development from marine natural products

  2009cited by this paper
• On the selective N-methylation of BOC-protected amino acids.

  2009cited by this paper
• Intravesical Chemotherapy of High-Grade Bladder Cancer with HTI-286, A Synthetic Analogue of the Marine Sponge Product Hemiasterlin

  2008cited by this paper
• Targeting prostate cancer with HTI‐286, a synthetic analog of the marine sponge product hemiasterlin

  2008cited by this paper
• Tubulin-interactive natural products as anticancer agents.

  2008cited by this paper
• Evaluation of antimitotic agents by quantitative comparisons of their effects on the polymerization of purified tubulin

  2007cited by this paper
• Advances in methods and algorithms in a modern quantum chemistry program package.

  2006cited by this paper
• Mapping the bound conformation and protein interactions of microtubule destabilizing peptides by STD-NMR spectroscopy.

  2006cited by this paper
• Structure-based identification of the binding site for the hemiasterlin analogue HTI-286 on tubulin.

  2005cited by this paper
• Hybrids of the hemiasterlin analogue taltobulin and the dolastatins are potent antimicrotubule agents.

  2005cited by this paper
• Taltobulin : Oncolytic drug Prop INN tubulin polymerization inhibitor antimitotic drug

  2005cited by this paper
• Classical and dynamic resolution of 1 -amino-3-methyl-1 ,3,4,5-tetrahydrobenzo[d]azepin-2-one

  2005cited by this paper
• Synthesis and biological activity of analogues of the antimicrotubule agent N, β, β-trimethyl-L-phenylalanyl-N1-[(1S, 2E)-3-carboxy-1-isopropylbut-2-enyl]-N1, 3 -dimethyl-L-valinamide (HTI-286)

  2004cited by this paper
• Cells resistant to HTI-286 do not overexpress P-glycoprotein but have reduced drug accumulation and a point mutation in alpha-tubulin.

  2004cited by this paper
• Synthesis and activity of novel analogs of hemiasterlin as inhibitors of tubulin polymerization: modification of the A segment.

  2004cited by this paper
• Synthesis and biological activity of analogues of the antimicrotubule agent N,beta,beta-trimethyl-L-phenylalanyl-N(1)-[(1S,2E)-3-carboxy-1-isopropylbut-2-enyl]- N(1),3-dimethyl-L-valinamide (HTI-286).

  2004cited by this paper
• D-piece modifications of the hemiasterlin analog HTI-286 produce potent tubulin inhibitors.

  2004cited by this paper
• The clinical development of new mitotic inhibitors that stabilize the microtubule.

  2004cited by this paper
• Localization of the antimitotic peptide and depsipeptide binding site on beta-tubulin.

  2004cited by this paper
• Synthesis and antimitotic/cytotoxic activity of hemiasterlin analogues.

  2003cited by this paper
• Natural, semisynthetic and synthetic microtubule inhibitors for cancer therapy

  2003cited by this paper
• HTI-286, a synthetic analogue of the tripeptide hemiasterlin, is a potent antimicrotubule agent that circumvents P-glycoprotein-mediated resistance in vitro and in vivo.

  2003cited by this paper
• A total synthesis of (-)-hemiasterlin using N-Bts methodology.

  2001cited by this paper
• Tubulin as a target for anticancer drugs.

  2000cited by this paper
• Interactions of the sponge-derived antimitotic tripeptide hemiasterlin with tubulin: comparison with dolastatin 10 and cryptophycin 1.

  1999cited by this paper
• Cytotoxic and tubulin-interactive hemiasterlins from Auletta sp. and Siphonochalina spp. sponges.

  1999cited by this paper
• Tubulin as a target for anticancer drugs: Agents which interact with the mitotic spindle

  1998cited by this paper
• Total synthesis of (−)-hemiasterlin, a structurally novel tripeptide that exhibits potent cytotoxic activity

  1997cited by this paper
• Cytotoxic peptides hemiasterlin, hemiasterlin A and hemiasterlin B induce mitotic arrest and abnormal spindle formation

  1996cited by this paper
• Cytotoxic peptides from the marine sponge Cymbastela sp.

  1995cited by this paper
• Hemiasterlin and geodiamolide TA; two new cytotoxic peptides from the marine sponge Hemiasterella minor (Kirkpatrick)

  1994cited by this paper

• Total Synthesis of Thiamyxins A-C and Thiamyxin E, a Potent Class of RNA-Virus-Inhibiting (Cyclo)depsipeptides.

  2023cites this paper
• Constraining the Side Chain of C-Terminal Amino Acids in Apelin-13 Greatly Increases Affinity, Modulates Signaling, and Improves the Pharmacokinetic Profile.

  2021cites this paper
• Natural products against cancer: Review on phytochemicals from marine sources in preventing cancer

  2019cites this paper
• Tubulin Inhibitor-Based Antibody-Drug Conjugates for Cancer Therapy

  2017cites this paper
• Complementary isonitrile-based multicomponent reactions for the synthesis of diversified cytotoxic hemiasterlin analogues.

  2015cites this paper